(Q41190039)

28 September 2017

title

The Helsinki Heart Study: central findings and clinical implications (English)

1 reference

28 September 2017

Huttunen JK

1

1 reference

28 September 2017

Manninen V

2

1 reference

28 September 2017

Mänttäri M

3

1 reference

28 September 2017

Koskinen P

4

1 reference

28 September 2017

Romo M

5

1 reference

28 September 2017

Tenkanen L

6

1 reference

28 September 2017

Heinonen OP

7

1 reference

28 September 2017

Frick MH

8

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 April 1991

1 reference

28 September 2017

1 reference

28 September 2017

volume

23

1 reference

28 September 2017

issue

2

1 reference

28 September 2017

page(s)

155-159

1 reference

Maximal coronary flow and the concept of coronary vascular reserve

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148041

Review of lipid-lowering clinical trials in relation to observational epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148041

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148041

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148041

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148041

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148041

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148041

Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148041

Lipoproteins and coronary heart disease in the Helsinki Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148041

Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148041

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899109148041

10.3109/07853899109148041

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference